HU191512B - Process for production of dosed through the nose medical preparatives containing ergot-alcaloids - Google Patents

Process for production of dosed through the nose medical preparatives containing ergot-alcaloids Download PDF

Info

Publication number
HU191512B
HU191512B HU83323A HU32383A HU191512B HU 191512 B HU191512 B HU 191512B HU 83323 A HU83323 A HU 83323A HU 32383 A HU32383 A HU 32383A HU 191512 B HU191512 B HU 191512B
Authority
HU
Hungary
Prior art keywords
hydrogen
formula
nasal
dihydroergotamine
formulation
Prior art date
Application number
HU83323A
Other languages
English (en)
Hungarian (hu)
Inventor
Jean-Rene Kiechel
Danielle Plas
Francoise Acezat-Mispelter
Original Assignee
Sandoz Ag,Ch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag,Ch filed Critical Sandoz Ag,Ch
Publication of HU191512B publication Critical patent/HU191512B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU83323A 1982-02-01 1983-01-31 Process for production of dosed through the nose medical preparatives containing ergot-alcaloids HU191512B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
HU191512B true HU191512B (en) 1987-02-27

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
HU83323A HU191512B (en) 1982-02-01 1983-01-31 Process for production of dosed through the nose medical preparatives containing ergot-alcaloids

Country Status (27)

Country Link
JP (1) JPS58134017A (it)
AT (1) AT385656B (it)
AU (1) AU565613B2 (it)
BE (1) BE895750A (it)
CA (1) CA1197783A (it)
CH (1) CH653555A5 (it)
DE (1) DE3302949A1 (it)
DK (1) DK164771C (it)
ES (1) ES519450A0 (it)
FI (1) FI81258C (it)
FR (1) FR2539994B1 (it)
GR (1) GR81320B (it)
HK (1) HK59989A (it)
HU (1) HU191512B (it)
IE (1) IE54532B1 (it)
IL (1) IL67822A (it)
IT (1) IT1197558B (it)
KE (1) KE3888A (it)
LU (1) LU84613A1 (it)
MY (1) MY8700766A (it)
NL (1) NL192325C (it)
NZ (1) NZ203117A (it)
PH (1) PH22198A (it)
PT (1) PT76166B (it)
SE (1) SE454402B (it)
SG (1) SG34389G (it)
ZA (1) ZA83673B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
KR20200118032A (ko) * 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
ES8502865A1 (es) 1985-02-01
DK164771B (da) 1992-08-17
JPH0253406B2 (it) 1990-11-16
NL8300325A (nl) 1983-09-01
ES519450A0 (es) 1985-02-01
SE454402B (sv) 1988-05-02
BE895750A (fr) 1983-08-01
PT76166A (en) 1983-02-01
ATA30383A (de) 1987-10-15
FI81258B (fi) 1990-06-29
DK38183A (da) 1983-08-02
IL67822A (en) 1988-02-29
IL67822A0 (en) 1983-06-15
FR2539994B1 (fr) 1986-10-10
AT385656B (de) 1988-05-10
GR81320B (it) 1984-12-11
AU1085083A (en) 1983-08-11
CA1197783A (en) 1985-12-10
IE54532B1 (en) 1989-11-08
LU84613A1 (fr) 1983-09-08
MY8700766A (en) 1987-12-31
IE830187L (en) 1983-08-01
SE8300495L (sv) 1983-08-02
DE3302949A1 (de) 1983-08-11
FI830245L (fi) 1983-08-02
NZ203117A (en) 1986-12-05
HK59989A (en) 1989-08-04
FI830245A0 (fi) 1983-01-25
DE3302949C2 (it) 1992-05-21
DK164771C (da) 1992-12-28
SE8300495D0 (sv) 1983-01-31
CH653555A5 (de) 1986-01-15
PH22198A (en) 1988-06-28
NL192325B (nl) 1997-02-03
FR2539994A1 (fr) 1984-08-03
IT8347646A0 (it) 1983-02-01
IT1197558B (it) 1988-12-06
SG34389G (en) 1989-09-22
FI81258C (fi) 1990-10-10
KE3888A (en) 1989-09-01
AU565613B2 (en) 1987-09-24
JPS58134017A (ja) 1983-08-10
NL192325C (nl) 1997-06-04
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
US5169849A (en) Nasal pharmaceutical compositions
US11717571B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
ES2626134T3 (es) Composiciones de bepotastina
AU714303B2 (en) Formulation for intranasal administration
AU724728B2 (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HU199678B (en) Process for producing aerosols containing nitroglicerol
US20040171666A1 (en) Therapeutic compositions for intranasal administration which include KETOROLAC
NZ263891A (en) Pharmaceutical composition of progesterone and/or 17-beta-estradiol, the active ingredient(s) being dissolved in an oil that is the inner phase of an oil-water two-phase system
RU2373925C2 (ru) Назальные фармацевтические композиции и способы их применения
CZ20032752A3 (cs) Přípravky pro nasální aplikaci, obsahující imidazotriazinon
US4885305A (en) Nasal compositions
US20080176913A1 (en) Transdermal compositions of pramipexole having enhanced permeation properties
HU191512B (en) Process for production of dosed through the nose medical preparatives containing ergot-alcaloids
GB2114001A (en) Nasal pharmaceutical compositions
AU2021254650B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
WO2006093786A2 (en) Scopolamine sublingual spray
KR100384346B1 (ko) 엘레트립탄 헤미술페이트 및 카페인을 포함하는 약제학적조성물
WO2021044357A1 (en) Apomorphine formulation
HU211543A9 (hu) Hajtógáz nélküli nitroglicerin aeroszol helyi alkalmazás céljára Az átmeneti oltalom az 1-5. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: NOVARTIS AG, CH